Search Results - Arnold Reuser

Refine Results
  1. 1
    Characterization of the human lysosomal α-glucosidase gene

    Characterization of the human lysosomal α-glucosidase gene by Lies H. Hoefsloot, Marianne Hoogeveen‐Westerveld, Arnold Reuser, Ben A. Oostra

    Published 1990
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man.

    Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. by Alessandra d’Azzo, A. T. Hoogeveen, Arnold Reuser, Douglas N. Robinson, H. Galjaard

    Published 1982
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Defects in synthesis, phosphorylation, and maturation of acid alpha-glucosidase in glycogenosis type II.

    Defects in synthesis, phosphorylation, and maturation of acid alpha-glucosidase in glycogenosis type II. by Arnold Reuser, Marian A. Kroos, Ronald P.J. Oude Elferink, J. M. Tager

    Published 1985
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Human lysosomal alpha-glucosidase. Characterization of the catalytic site

    Human lysosomal alpha-glucosidase. Characterization of the catalytic site by M M Hermans, Marian A. Kroos, J. Van Beeumen, Ben A. Oostra, Arnold Reuser

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation.

    Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation. by H.A. Wisselaar, Marian A. Kroos, M M Hermans, J. Van Beeumen, Arnold Reuser

    Published 1993
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts.

    Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts. by Arnold Reuser, Marian A. Kroos, Rob Willemsen, Dallas M. Swallow, J. M. Tager, H. Galjaard

    Published 1987
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex.

    Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex. by L. H. Hoefsloot, Marianne Hoogeveen‐Westerveld, Marian A. Kroos, J. Van Beeumen, Arnold Reuser, B. A. Oostra

    Published 1988
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease

    Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease by Carin M. Van Gelder, Marianne Hoogeveen‐Westerveld, Marian A. Kroos, Iris Plug, Ans T. van der Ploeg, Arnold Reuser

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Hearing loss in Pompe disease revisited: results from a study of 24 children

    Hearing loss in Pompe disease revisited: results from a study of 24 children by Carine I. van Capelle, André Goedegebure, Nienke C. Homans, L.J. Hoeve, Arnold Reuser, Ans T. van der Ploeg

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Introduction of a viral thymidine kinase gene and the human β-globin gene into developmentally multipotential mouse teratocarcinoma cells

    Introduction of a viral thymidine kinase gene and the human β-globin gene into developmentally multipotential mouse teratocarcinoma cells by Ángel Pellicer, Erwin F. Wagner, Adele El Kareh, Michael J. Dewey, Arnold Reuser, Saul J. Silverstein, Richard Axel, Beatrice Mintz

    Published 1980
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating

    Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating by Marian A. Kroos, Robert J. Pomponio, Laura Van de Vliet, Rachel Palmer, Michael Phipps, Robert van der Helm, Dicky Halley, Arnold Reuser

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Fatigue: an important feature of late-onset Pompe disease

    Fatigue: an important feature of late-onset Pompe disease by M.L.C. Hagemans, S. P. M. van Schie, A. Cecile J.W. Janssens, P.A. van Doorn, Arnold Reuser, Ans T. van der Ploeg

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations

    A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations by Andreas Herzog, Ralf Hartung, Arnold Reuser, Pia Hermanns, Heiko Runz, Nesrin Karabul, Seyfullah Gökce, Joachim Pohlenz, Christoph Kampmann, Christina Lampe, Michael Beck, Eugen Mengel

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy

    Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy by Deniz Güngör, Juna M. de Vries, Wim C.J. Hop, Arnold Reuser, Pieter A. van Doorn, Ans T. van der Ploeg, M.L.C. Hagemans

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Effects of a higher dose of alglucosidase alfa on ventilator‐free survival and motor outcome in classic infantile Pompe disease: an open‐label single‐center study

    Effects of a higher dose of alglucosidase alfa on ventilator‐free survival and motor outcome in classic infantile Pompe disease: an open‐label single‐center study by Carin M. Van Gelder, Esther Poelman, Iris Plug, Marianne Hoogeveen‐Westerveld, Nadine A. M. E. van der Beek, Arnold Reuser, Ans T. van der Ploeg

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study

    Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study by Deniz Güngör, Michelle E. Kruijshaar, Iris Plug, Ralph B. D’Agostino, M.L.C. Hagemans, Pieter A. van Doorn, Arnold Reuser, Ans T. van der Ploeg

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Glycogenosis type II (acid maltase deficiency)

    Glycogenosis type II (acid maltase deficiency) by Arnold Reuser, Marian A. Kroos, M M Hermans, A. G. A. Bijvoet, Martin Ph. Verbeet, O. P. van Diggelen, Wim J. Kleijer, Ans T. van der Ploeg

    Published 1995
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow‐up

    Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow‐up by Deniz Güngör, Michelle E. Kruijshaar, Iris Plug, Dimitris Rizopoulos, Tim A. Kanters, Stephan C.A. Wens, Arnold Reuser, Pieter A. van Doorn, Ans T. van der Ploeg

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Characterization and localization of the FMR-1 gene product associated with fragile X syndrome

    Characterization and localization of the FMR-1 gene product associated with fragile X syndrome by Coleta Verheij, Cathy Bakker, Esther de Graaff, J. L. M. Keulemans, Rob Willemsen, Annemieke J.M.H. Verkerk, H. Galjaard, Arnold Reuser, A. T. Hoogeveen, Ben A. Oostra

    Published 1993
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase

    Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase by Marion M. Brands, Marianne Hoogeveen‐Westerveld, Marian A. Kroos, Willemieke Nobel, George J. G. Ruijter, Lale Özkan, Iris Plug, Daniel Grinberg, Lluı̈sa Vilageliu, Dicky Halley, Ans T. van der Ploeg, Arnold Reuser

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: